Your browser doesn't support javascript.
loading
The role of E3 ubiquitin ligase in multiple myeloma: potential for cereblon E3 ligase modulators in the treatment of relapsed/refractory disease.
Richardson, Paul G; Mateos, María-Victoria; Vangsted, Annette J; Ramasamy, Karthik; Abildgaard, Niels; Ho, P Joy; Quach, Hang; Bahlis, Nizar J.
Afiliação
  • Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Mateos MV; Haematology Department, University Hospital of Salamanca/IBSAL, Salamanca, Spain.
  • Vangsted AJ; Department of HaematologyRigshospitalet, Copenhagen, Denmark.
  • Ramasamy K; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Abildgaard N; Hematology Research Unit, Department of Hematology, Odense University Hospital, Odense, Denmark; and Department of Clinical Research.
  • Ho PJ; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Quach H; Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Bahlis NJ; Sydney Medical School, University of Sydney, Camperdown, NSW, Australia.
Expert Rev Proteomics ; 19(4-6): 235-246, 2022.
Article em En | MEDLINE | ID: mdl-36342226
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ubiquitina-Proteína Ligases / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ubiquitina-Proteína Ligases / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article